Trial Profile
Long-term effects of subcutaneous treprostinil in pulmonary arterial hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2015
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Therapeutic Use
- 12 Nov 2015 New trial record